Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1515 Articles

Chris Lange | May 11, 2017 at 10:30 AM EDT

Why Sangamo Therapeutics Is Surging

Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.

Chris Lange | May 10, 2017 at 9:00 AM EDT

Short Interest in Major Pharma Shrinks

The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 2, 2017 at 8:50 AM EDT

Pfizer Sinks on Mixed Q1 Earnings

Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.

Chris Lange | May 1, 2017 at 11:30 AM EDT

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly…

Chris Lange | Apr 30, 2017 at 9:25 AM EDT

Facebook, Tesla and More Major Earnings Coming Out This Week

24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting…

Chris Lange | Apr 26, 2017 at 8:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Paul Ausick | Apr 11, 2017 at 4:01 PM EDT

Apple, DuPont Sink DJIA Tuesday

Apple, DuPont, Goldman Sachs, and Pfizer led the DJIA to a lower close on Tuesday.

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 27, 2017 at 6:50 AM EDT

The 6 Most Shorted NYSE Stocks

With the major markets retreating from all-time highs, it began to look like the Trump rally was spent. Judging by…

Chris Lange | Mar 25, 2017 at 9:15 AM EDT

How Health Care Stocks Responded to the Shelved Health Care Bill

24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen…

Paul Ausick | Mar 24, 2017 at 4:01 PM EDT

DuPont, Boeing Sink DJIA Friday

Goldman Sachs, DuPont, Boeing, and Pfizer weighed on the Dow Jones Industrial Average Friday.

Paul Ausick | Mar 16, 2017 at 4:05 PM EDT

DuPont, Chevron Take DJIA Down Thursday

DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.

Chris Lange | Mar 10, 2017 at 8:55 AM EST

Short Sellers Back Off Major Pharma

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 10, 2017 at 6:10 AM EST

The 6 Most Shorted NYSE Stocks

The bull market is now eight years old, and markets still keep on hitting new highs. How have the short…

1 … 43 44 45 46 47 … 101

Pfizer : PFE

All Pfizer Articles

Why Sangamo Therapeutics Is Surging

Short Interest in Major Pharma Shrinks

Pfizer Sinks on Mixed Q1 Earnings

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

Facebook, Tesla and More Major Earnings Coming Out This Week

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Run for Cover From Major Pharma Stocks

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The 6 Most Shorted NYSE Stocks

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Boeing Sink DJIA Friday

DuPont, Chevron Take DJIA Down Thursday

Short Sellers Back Off Major Pharma

The 6 Most Shorted NYSE Stocks

Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Live: Will Intuitive Surgical Smash Tonight’s Q2 Earnings After 29% YTD Decline?

Live: Will Netflix’s Q2 Earnings Tonight Spark a Rebound for the Stock?

XRP Price Prediction: Can XRP Hit Double Digits?

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn’t a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn't a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare

XRP Price Prediction: Can XRP Hit Double Digits?

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

Pfizer : PFE

All Pfizer Articles

Why Sangamo Therapeutics Is Surging

Short Interest in Major Pharma Shrinks

Pfizer Sinks on Mixed Q1 Earnings

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

Facebook, Tesla and More Major Earnings Coming Out This Week

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Run for Cover From Major Pharma Stocks

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The 6 Most Shorted NYSE Stocks

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Boeing Sink DJIA Friday

DuPont, Chevron Take DJIA Down Thursday

Short Sellers Back Off Major Pharma

The 6 Most Shorted NYSE Stocks

Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Live: Will Intuitive Surgical Smash Tonight’s Q2 Earnings After 29% YTD Decline?

Live: Will Netflix’s Q2 Earnings Tonight Spark a Rebound for the Stock?

XRP Price Prediction: Can XRP Hit Double Digits?

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn’t a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare

Featured Reads

A 70-Year-Old With $600,000 Delays Social Security for the 8% Bonus, and Walks Into a Bigger RMD

IRMAA Isn't a Tax, but a Retired Couple Can Pay $8,000+ a Year Extra for the Same Medicare